Founded in 2013, Shandong Fulaichen Biotechnology Co., Ltd is located in the Weifang city of Shandong Province with a registered capital of CNY 50 million. As the largest crude product manufacturer of Human menopausal gonadotropin (HMG) and Human chorionic gonadotropin (HCG), Fulaichen is mainly engaged in the research and development, production and trade of biomedical products. Sticking to such enterprise development concept of "be people-oriented, getting development by leading technology, be honest and high efficient, and win-win cooperation", we strive to win the market with superior quality and high-tech products. We aim to get further progress in such technological way of high technological contents and added-values.

 

Since our inception, our company has attached great importance to scientific and technological innovation, and the research and development of new products; we expand the market and purchase raw materials continuously through increasing R&D investments year by year. At present, our company has more than 10 subsidiaries and more than 200 employees; with the help of over 2,000 urine collectors and about 150,000 urine providers, we are able to collect 150 tons to 200 tons of human urine every day; now, we produce 1,000kg of crude HMG products and 800kg of crude HCG products annually.

 

In August 2017, our company signed a cooperation agreement with the Chinese Academy of Sciences Guangzhou Biopharmaceutical and Health Research Institute: we are committed to the research, development and production of high-end HMG and HCG export-grade products and related pharmaceutical series to meet the needs of markets and consumers.